Navigation Links
Lung Cancer Alliance Salutes National Comprehensive Cancer Network (NCCN) for Its Lung Cancer Screening Guidelines
Date:10/28/2011

WASHINGTON, Oct. 28, 2011 /PRNewswire-USNewswire/ --Today Lung Cancer Alliance (LCA) hailed the leadership of the National Comprehensive Cancer Network (NCCN) for being the first professional society to recommend low-dose CT screening for high risk individuals and to develop comprehensive clinical practice guidelines on lung cancer screening.    

NCCN is a consortia of 21 of the world's leading cancer centers dedicated to improving the quality and effectiveness of care provided to patients with cancer.  

Released October 26, 2011, the NCCN guidelines stem from the landmark November 2010 decision by the National Cancer Institute (NCI) to halt its eight-year National Lung Screening Trial (NLST) because the study found  that screening people at high risk for lung cancer with low-dose (LDCT) scans reduced lung cancer mortality by 20%.

In the absence of screening, lung cancer is generally found after it has spread beyond the lung and existing treatments are rarely curative. Lung cancer alone accounts for close to one in three cancers deaths and is the leading cause of cancer death across the world.

"We appreciate NCCN's recognition of the urgency of the situation and working to allow the life-saving potential of CT screening to move swiftly and thoughtfully to clinical implementation." said Laurie Fenton Ambrose, LCA President & CEO.  As the leading national voice for patients and those at risk for lung cancer and as a consistent advocate for early detection and increased research funding for the disease, LCA will continue to work with respected professional societies to ensure the benefit of CT screening is  available to those at risk in a safe, efficient and equitable way."

The NCCN guidelines provide important clinical information on risk factors for lung cancer, criteria for selecting high-risk individuals for screening, recommendations for evaluation and follow-up of nodules found durin
'/>"/>

SOURCE Lung Cancer Alliance
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. ReportsnReports - Hyper Acute Pancreas (Pancreatic Cancer) - Analysis and Forecasts to 2020
2. ALIMTA First Chemotherapy Approved in Europe as Continuation Maintenance Therapy for Most Common Form of Lung Cancer
3. Groundbreaking Approach to Predicting Cancer Patients Response to Treatment Featured in Science Magazine
4. Phase 3 Trial of Investigational Compound Regorafenib in Metastatic Colorectal Cancer Meets Primary Endpoint of Improving Overall Survival
5. CDC Launches Effort to Protect Cancer Patients From Infections
6. Laparoscopic Surgeons Develop Fluorescent Light Technique to Improve Pancreatic Cancer Detection
7. Gastric Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Volume I 2011
8. Runners Take to the Streets in Undies to Fight Colon Cancer
9. HIFU All Hype? Understanding This Non-FDA-Approved Prostate Cancer Treatment
10. Advances in Radiotherapy Detailed at Cancer Summit Organized by Varian Medical Systems
11. Afinitor (Breast Cancer) - Analysis and Forecasts to 2020
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... , July 2, 2015 The ... & Heterofermentative), Species (Lactobacillus, Pediococcus & Enterococcus), Enzymes (Fibre-digesting ... Forecast to 2020", Silage Inoculants & Enzymes Market is ... CAGR of 4.0% from 2015 to 2020. ... igures spread through 194 P ages ...
(Date:7/2/2015)... 2015 BGI gab heute bekannt, ... vom American College of Pathologists (CAP) akkreditiert ... erste klinische Next-Generation-Sequencing Labor, das in ... und somit die höchsten Standards an klinischer ... FDA - 21 CFR Part 11 konformen ...
(Date:7/2/2015)... Ill. , July 2, 2015  AbbVie (NYSE: ... results on Friday, July 24, 2015, before the market ... of the earnings conference call at 8 a.m. Central ... AbbVie,s Investor Relations website at www.abbvieinvestor.com . An ... 11 a.m. Central time. About AbbVie ...
Breaking Medicine Technology:Silage Inoculants & Enzymes Market Worth $489.05 Million by 2020 2Silage Inoculants & Enzymes Market Worth $489.05 Million by 2020 3Silage Inoculants & Enzymes Market Worth $489.05 Million by 2020 4BGI erhält Akkreditierung vom College of American Pathologists (CAP) 2
... , WALTHAM, ... the world,s leading research and advisory firms focusing on pharmaceutical ... market in Brazil will grow from $417 million in 2008 ... growth rate is attributed to a growing prevalent and drug-treated ...
... 3 New state investments will help an Adams ... facility and help a Philadelphia pharmaceutical distributor expand operations ... Rendell announced today. , The Pennsylvania Industrial Development Authority ... The investments, in the form of low-interest loans, will ...
Cached Medicine Technology:Brazil's Type 2 Diabetes Drug Market Will Grow to $834 Million by 2013 2Brazil's Type 2 Diabetes Drug Market Will Grow to $834 Million by 2013 3Governor Rendell: New State Investments Bear Fruit in Adams County; Help Pharmaceutical Company Expand in Philadelphia 2
(Date:7/2/2015)... CA (PRWEB) , ... July 02, 2015 , ... ... of Dr. Divakar R. Krishnareddy, M.D., to the orthopedic and spine surgery team ... disc herniations, sprains, strains, bursitis, and tendonitis. Along with the spine and spine ...
(Date:7/2/2015)... ... July 02, 2015 , ... ... consulting services to the federal government, has announced they are among nine contractors ... Management Office Support Services (BMOSS) contract not to exceed $250 million. , ...
(Date:7/2/2015)... ... July 02, 2015 , ... B. E. Smith, the ... to lead a national chief executive officer recruitment for Indiana Blood ... healthcare industry, B. E. Smith has recently placed more than 1,000 healthcare executives ...
(Date:7/2/2015)... ... 2015 , ... AvePoint Public Sector, Inc., a wholly owned subsidiary ... today announced it was named the recipient of the 2015 GTRA ConVurge Tech Award ... by the Government Technology Research Alliance (GTRA), was presented June 29 during the ConVurge ...
(Date:7/2/2015)... Liverpool, Ohio (PRWEB) , ... July 02, 2015 , ... ... as Director of the Surgical Center at East Liverpool City Hospital (ELCH). Pam is ... assume the duties of the director of surgery. Pam holds a master’s degree in ...
Breaking Medicine News(10 mins):Health News:Healthpointe Welcomes Dr. Divakar R. Krishnareddy to its Orthopedic Team in Anaheim 2Health News:Healthpointe Welcomes Dr. Divakar R. Krishnareddy to its Orthopedic Team in Anaheim 3Health News:Octo Consulting Group Awarded IDIQ Contract for SEC Business Management Support 2Health News:Indiana Blood Center Retains B. E. Smith to Recruit New Chief Executive Officer 2Health News:Indiana Blood Center Retains B. E. Smith to Recruit New Chief Executive Officer 3Health News:AvePoint Public Sector Wins 2015 GTRA ConVurge Tech Award for Excellence in Government SaaS 2Health News:AvePoint Public Sector Wins 2015 GTRA ConVurge Tech Award for Excellence in Government SaaS 3Health News:AvePoint Public Sector Wins 2015 GTRA ConVurge Tech Award for Excellence in Government SaaS 4Health News:East Liverpool City Hospital Announces New Surgical Center Leadership 2Health News:East Liverpool City Hospital Announces New Surgical Center Leadership 3
... better prognosis, study finds , , FRIDAY, Dec. 12 (HealthDay News) ... the risk of getting breast cancer, but women who take ... risk of dying from the disease, a new study suggests. ... particular type of cancer that is easier to treat," explained ...
... Ariz., Dec. 12 Roberta Kalafut, D.O., just announced her ... to a close the worst abuses of power by the ... unjust disciplinary actions, particularly against her competitors, and stonewalling by ... , "We applaud Kalafut,s resignation," said AAPS Executive ...
... Fair Offers New Chemists and Chemical Engineers an Opportunity to ... , PRINCETON, N.J., Dec. 12 Informex ... the upcoming InformexUSA exhibition in San Francisco free of charge. ... 25 and under to learn more about the chemical technologies ...
... saw disease stabilize or improve, study shows , , ... combination of medicines designed to boost immune function ... interim results from an ongoing Mayo Clinic study. ... immunomodulatory drug called pomalidomide with dexamethasone (pom/dex) improved ...
... At its 12th annual holiday gala The,Teddy Bear ... Award to Steve,Mosko, President of Sony Pictures Television ... to children with special needs. Grammy(R),winning singer-songwriter Kenny ... of the Heart. Long standing friend and colleague ...
... YORK, Dec. 12 In his last public remarks as,the ... Lilly and Company (NYSE: LLY ), today said ... markets and regulatory environments,encourage and reward companies for the long-term, ... bench to the bedside. , ...
Cached Medicine News:Health News:HRT Users Who Get Breast Cancer Less Likely to Die 2Health News:HRT Users Who Get Breast Cancer Less Likely to Die 3Health News:AAPS Applauds the Resignation of TMB President Roberta Kalafut, Mari Robinson Should Resign Next 2Health News:Informex Invites Young Chemists to Attend InformexUSA 2Health News:Informex Invites Young Chemists to Attend InformexUSA 3Health News:Combo Therapy Helps Multiple Myeloma Patients 2Health News:The Help Group's Teddy Bear Ball Salutes Sony Pictures Television President, Steve Mosko and Features Performance by Kenny Loggins 2Health News:Lilly Chairman Taurel Says Promise of Personalized Medicine Could be Jeopardized by Short-Sighted Public Policies 2Health News:Lilly Chairman Taurel Says Promise of Personalized Medicine Could be Jeopardized by Short-Sighted Public Policies 3
... is a high precision optical system for ... the anterior eye segment, based on a ... Placido Disk. , GALILEI combines the advantages ... accuracy curvature data, while Scheimpflug imaging is ...
... The C-VUE 55 Toric Multifocal ... also have presbyopia with all day ... visual acuity at every distance. This ... wide range of parameters with ADDs ...
... Nicknamed the SRS, this new and innovative stent ... the office right at the chair with just ... medical grade silicone and is available in three ... separately). At each end of the stent is ...
... Using flying spot technology the Technolas 217z ... for personalized vision correction, allows surgeons in ... to -7.00 Diopters and astigmatism up to ... combines both a 2mm and 1mm truncated ...
Medicine Products: